Cargando…
Retinopathy of prematurity: Metabolic risk factors
At preterm birth, the retina is incompletely vascularized. Retinopathy of prematurity (ROP) is initiated by the postnatal suppression of physiological retinal vascular development that would normally occur in utero. As the neural retina slowly matures, increasing metabolic demand including in the pe...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691009/ https://www.ncbi.nlm.nih.gov/pubmed/36420952 http://dx.doi.org/10.7554/eLife.80550 |
_version_ | 1784836937641623552 |
---|---|
author | Fu, Zhongjie Nilsson, Anders K Hellstrom, Ann Smith, Lois EH |
author_facet | Fu, Zhongjie Nilsson, Anders K Hellstrom, Ann Smith, Lois EH |
author_sort | Fu, Zhongjie |
collection | PubMed |
description | At preterm birth, the retina is incompletely vascularized. Retinopathy of prematurity (ROP) is initiated by the postnatal suppression of physiological retinal vascular development that would normally occur in utero. As the neural retina slowly matures, increasing metabolic demand including in the peripheral avascular retina, leads to signals for compensatory but pathological neovascularization. Currently, only late neovascular ROP is treated. ROP could be prevented by promoting normal vascular growth. Early perinatal metabolic dysregulation is a strong but understudied risk factor for ROP and other long-term sequelae of preterm birth. We will discuss the metabolic and oxygen needs of retina, current treatments, and potential interventions to promote normal vessel growth including control of postnatal hyperglycemia, dyslipidemia and hyperoxia-induced retinal metabolic alterations. Early supplementation of missing nutrients and growth factors and control of supplemental oxygen promotes physiological retinal development. We will discuss the current knowledge gap in retinal metabolism after preterm birth. |
format | Online Article Text |
id | pubmed-9691009 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-96910092022-11-25 Retinopathy of prematurity: Metabolic risk factors Fu, Zhongjie Nilsson, Anders K Hellstrom, Ann Smith, Lois EH eLife Medicine At preterm birth, the retina is incompletely vascularized. Retinopathy of prematurity (ROP) is initiated by the postnatal suppression of physiological retinal vascular development that would normally occur in utero. As the neural retina slowly matures, increasing metabolic demand including in the peripheral avascular retina, leads to signals for compensatory but pathological neovascularization. Currently, only late neovascular ROP is treated. ROP could be prevented by promoting normal vascular growth. Early perinatal metabolic dysregulation is a strong but understudied risk factor for ROP and other long-term sequelae of preterm birth. We will discuss the metabolic and oxygen needs of retina, current treatments, and potential interventions to promote normal vessel growth including control of postnatal hyperglycemia, dyslipidemia and hyperoxia-induced retinal metabolic alterations. Early supplementation of missing nutrients and growth factors and control of supplemental oxygen promotes physiological retinal development. We will discuss the current knowledge gap in retinal metabolism after preterm birth. eLife Sciences Publications, Ltd 2022-11-24 /pmc/articles/PMC9691009/ /pubmed/36420952 http://dx.doi.org/10.7554/eLife.80550 Text en © 2022, Fu et al https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Medicine Fu, Zhongjie Nilsson, Anders K Hellstrom, Ann Smith, Lois EH Retinopathy of prematurity: Metabolic risk factors |
title | Retinopathy of prematurity: Metabolic risk factors |
title_full | Retinopathy of prematurity: Metabolic risk factors |
title_fullStr | Retinopathy of prematurity: Metabolic risk factors |
title_full_unstemmed | Retinopathy of prematurity: Metabolic risk factors |
title_short | Retinopathy of prematurity: Metabolic risk factors |
title_sort | retinopathy of prematurity: metabolic risk factors |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691009/ https://www.ncbi.nlm.nih.gov/pubmed/36420952 http://dx.doi.org/10.7554/eLife.80550 |
work_keys_str_mv | AT fuzhongjie retinopathyofprematuritymetabolicriskfactors AT nilssonandersk retinopathyofprematuritymetabolicriskfactors AT hellstromann retinopathyofprematuritymetabolicriskfactors AT smithloiseh retinopathyofprematuritymetabolicriskfactors |